Defining the Language Phenotype of the FMR1 Premutation

定义 FMR1 前突变的语言表型

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Although the FMR1 premutation is a common genetic abnormality that affects 1:151 women in the US, relatively little is known about its clinical phenotype. A growing number of studies indicate that mothers who are carriers of the FMR1 premutation struggle with pragmatic aspects of language. However, it is unclear whether other aspects of oral or written language are also impaired in premutation carrier mothers, as there have been no systematic investigations of language in this population. Understanding the full range of language difficulties experienced by premutation carrier mothers is important because even subtle language and literacy problems are linked with negative outcomes such as lower educational attainment, unemployment, poorer quality friendships, and psychiatric risk. These negative outcomes are particularly concerning when applied within the context of fragile X families because they may impact the ability of the premutation carrier mother to care and advocate for her disabled children with fragile X syndrome, thereby impacting quality of life for both the mother as well as her family. This proposal represents the first systematic investigation of language abilities in premutation carrier mothers. We seek to identify aspects of oral and written language that differentiate premutation carrier mothers from control mothers and mothers of children with autism spectrum disorder (ASD). Our inclusion of a control group of neurotypical mothers will allow us to identify aspects of the premutation language profile that are impaired relative to the healthy population. We also include comparison to mothers of children with ASD, who are at increased genetic liability to ASD and show subtle language difficulties associated with the broad autism phenotype. This cross-population comparison approach will inform phenotypic specificity and the range of language features that may be traced specifically to the biochemical effects of FMR1. We will also investigate the interplay between language and executive dysfunction, which is a well-documented aspect of the premutation phenotype and is hypothesized to influence language. Finally, we will examine association between language and FMR1 gene function. This research will refine our understanding of the full range of language phenotypes linked with FMR1 gene dysfunction and will inform the development of identification/treatment efforts targeted towards the specific needs of premutation carrier mothers and their families.
项目总结/摘要 虽然FMR 1前突变是一种常见的遗传异常,在美国影响1:151的女性, 关于其临床表型知之甚少。越来越多的研究表明, FMR 1前突变的携带者与语言的语用方面斗争。然而,目前尚不清楚是否 突变前携带者母亲的口头或书面语言的其他方面也受到损害,因为没有出现这种情况。 对这一人群的语言进行系统的调查。了解语言的各种困难 突变前携带者母亲经历的是重要的,因为即使是微妙的语言和识字问题, 与教育程度低、失业、质量差等负面结果有关 友谊和精神风险这些负面结果在适用于 脆性X家族的背景,因为它们可能会影响前突变携带者母亲照顾和 倡导她的残疾儿童与脆性X综合征,从而影响生活质量的母亲, 还有她的家人 这一建议代表了第一次系统的调查语言能力的前突变携带者 妈妈们我们试图确定口头和书面语言的方面,区分前突变携带者的母亲 来自对照组母亲和自闭症谱系障碍(ASD)儿童的母亲。我们包含一个控件 一组神经典型的母亲将使我们能够确定突变前语言特征的各个方面, 与健康人群相比,我们还包括与ASD儿童的母亲的比较, 自闭症的遗传易感性增加,并表现出与广泛自闭症相关的微妙的语言困难, 表型这种交叉群体比较方法将告知表型特异性和 这些语言特征可以特别追溯到FMR 1的生化作用。我们亦会研究 语言和执行功能障碍之间的相互作用,这是一个有据可查的方面, 表型,并假设影响语言。最后,我们将研究语言之间的联系。 FMR 1基因功能这项研究将完善我们对语言表型的全面理解 与FMR 1基因功能障碍有关,并将为针对性的识别/治疗工作的发展提供信息 针对突变前携带者母亲及其家庭的具体需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Klusek其他文献

Jessica Klusek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Klusek', 18)}}的其他基金

Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
  • 批准号:
    10813530
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
  • 批准号:
    10445687
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
  • 批准号:
    10664902
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
  • 批准号:
    10712277
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Aging Language Trajectories in Premutation Carrier Mothers
早突变携带者母亲的衰老语言轨迹
  • 批准号:
    9892021
  • 财政年份:
    2019
  • 资助金额:
    $ 14.65万
  • 项目类别:
Profiles and Predictors of Pragmatic Language Impairments in the FMR1 Premutation
FMR1 前突变中语用语言障碍的概况和预测因素
  • 批准号:
    8716154
  • 财政年份:
    2014
  • 资助金额:
    $ 14.65万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 14.65万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了